Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03707509
Brief Title: Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma

First Submitted : September 25, 2018
First Submitted that Met QC Criteria : October 14, 2018
First Posted : October 16, 2018

Last Update Submitted that Met QC Criteria : December 17, 2018
Last Update Posted : December 19, 2018